My research program centres on autonomic dysfunction and its consequences for quality of life, care, and health outcomes in conditions that disproportionately affect women. I established Australia's first national POTS registry, which has underpinned a series of studies examining quality of life, symptom burden, and patient experience in POTS, including the first Australian data quantifying how severely the condition affects daily functioning compared to healthy populations.

My program spans quantitative and qualitative methodologies. Quantitative work includes physiological studies of cerebral hypoperfusion in POTS, autonomic dysfunction in long COVID, and early investigations into autonomic contributions to spontaneous coronary artery dissection and vasospastic angina. Qualitative work has centred on patient experience, capturing the diagnostic journey, barriers to care, and the lived impact of under-recognised cardiovascular conditions.

A significant body of work has focused on long COVID, where my research was the first globally to characterise autonomic nervous system damage in this population as mechanistically comparable to POTS, contributing to national and international case definitions and policy responses.

Across all streams, knowledge translation is a core research value. Registry findings have been converted into clinical guidelines, GP education programs, and consumer resources, with a particular focus on bridging the gap between emerging evidence and frontline clinical practice.